| 1 | iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts. (Hess NJ, S Bharadwaj N, Bobeck EA, McDougal CE, Ma S, Sauer JD, Hudson AW, Gumperz JE) Life Sci Alliance 2021 Jul;4(7) 5 Citations |
| 1 | PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. (Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, Kraft AS, Yu XZ) J Clin Invest 2018 Jul 02;128(7):2787-2801 27 Citations |
| 1 | What's hot, what's new: Report from the American Transplant Congress 2017. (Cooper M, Li XC, Adams AB) Am J Transplant 2018 Feb;18(2):308-320 2 Citations |
| 1 | The immune reconstitution of the skin following sex-mismatched allogeneic haematopoietic stem cell transplant: a prospective case series utilizing fluorescence in situ hybridization and immunohistochemistry. (Stewart CL, Cornejo CM, Wanat KA, Sander I, Samimi S, Prouty S, Seykora J, Zhang P, Rosenbach M, Kim EJ, Micheletti RG) Br J Dermatol 2018 Jan;178(1):e55-e56 |
| 1 | Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation. (Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN) Biol Blood Marrow Transplant 2016 Aug;22(8):1368-1375 46 Citations |
| 1 | Advances in understanding the pathogenesis of graft-versus-host disease. (Magenau J, Runaas L, Reddy P) Br J Haematol 2016 Apr;173(2):190-205 67 Citations |
| 1 | Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease. (Hamadani M, Gibson LF, Remick SC, Wen S, Petros W, Tse W, Brundage KM, Vos JA, Cumpston A, Bunner P, Craig MD) J Clin Oncol 2013 Dec 10;31(35):4416-23 30 Citations |
| 1 | Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies. (Avigan D, Hari P, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Hsu KC) Biol Blood Marrow Transplant 2013 Dec;19(12):1661-9 11 Citations |
| 1 | Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. (Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S, Anasetti C, Gabrilovich D, Yu XZ) Biol Blood Marrow Transplant 2013 May;19(5):692-702 58 Citations |
| 1 | Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. (Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D, Cifuni SM, Fuchs TA, von Andrian UH, Hartwig JH, Aster RH, Wagner DD) Blood 2012 Jun 28;119(26):6335-43 248 Citations |
| 3 | A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 127 Citations |
| 1 | Clinical operational tolerance after renal transplantation: current status and future challenges. (Orlando G, Hematti P, Stratta RJ, Burke GW 3rd, Di Cocco P, Pisani F, Soker S, Wood K) Ann Surg 2010 Dec;252(6):915-28 110 Citations |
| 1 | Immune reconstitution: how it should work, what's broken, and why it matters. (Gress RE, Emerson SG, Drobyski WR) Biol Blood Marrow Transplant 2010 Jan;16(1 Suppl):S133-7 25 Citations |
| 2 | HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. (Baxter-Lowe LA, Maiers M, Spellman SR, Haagenson MD, Wang T, Fernandez-Vina M, Marsh SG, Horowitz M, Hurley CK) Biol Blood Marrow Transplant 2009 Aug;15(8):971-81 23 Citations |
| 2 | Comparison of twin and autologous transplants for multiple myeloma. (Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P, Plasma Cell Disorders Working Committee) Biol Blood Marrow Transplant 2008 Oct;14(10):1118-1124 26 Citations |
| 1 | Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. (Madrigal A, Shaw BE) Blood Cells Mol Dis 2008;40(1):40-3 13 Citations |
| 1 | Emergent autoimmunity in graft-versus-host disease. (Tivol E, Komorowski R, Drobyski WR) Blood 2005 Jun 15;105(12):4885-91 109 Citations |
| 4 | Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 57 Citations |
| 1 | Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. (Drobyski WR, Majewski D, Hanson G) Biol Blood Marrow Transplant 1999;5(4):222-30 61 Citations |
| 1 | Comparison of jejunal and ileal surveillance biopsies in a porcine model of intestinal transplantation. (Raofi V, Fontaine MJ, Mihalov ML, Holman DM, Dunn TB, Vitello JM, Asolati M, Kumins NH, Benedetti E) Transplantation 1999 Jul 27;68(2):188-91 3 Citations |
| 1 | A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. (Raofi V, Holman DM, Coady N, Vazquez E, Dunn TB, Bartholomew AM, Pollak R, Benedetti E) Am J Surg 1999 Apr;177(4):299-302 20 Citations |
